BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24621074)

  • 1. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.
    Gao C; Ma T; Pang L; Xie R
    Diagn Pathol; 2014 Mar; 9():55. PubMed ID: 24621074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and clinical significance of miR-132 in gastric cancer patients.
    Liu X; Yu H; Cai H; Wang Y
    Diagn Pathol; 2014 Mar; 9():57. PubMed ID: 24621117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J; Shang Y; Liu S; Piao Y; Cui X; Li Y; Lin Z
    Diagn Pathol; 2014 Mar; 9():67. PubMed ID: 24650035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
    Zhang M; Zhang C; Du W; Yang X; Chen Z
    Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
    Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?
    Kouraklis G; Katsoulis IE; Theocharis S; Tsourouflis G; Xipolitas N; Glinavou A; Sioka C; Kostakis A
    Dig Dis Sci; 2009 May; 54(5):1015-20. PubMed ID: 19058005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
    J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.
    Yang Y; Cai J; Yin J; Wang D; Bai Z; Zhang J; Wang K; Yu G; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(10):12482-90. PubMed ID: 26722435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancer.
    Niu Y; Li F; Tang B; Shi Y; Hao Y; Yu P
    Int J Clin Exp Pathol; 2014; 7(8):5144-53. PubMed ID: 25197388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis.
    Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G
    Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis.
    Joo YE; Oh WT; Rew JS; Park CS; Choi SK; Kim SJ
    Digestion; 2002; 66(4):222-9. PubMed ID: 12592098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
    Jin J; Jin T; Quan M; Piao Y; Lin Z
    Diagn Pathol; 2012 Oct; 7():135. PubMed ID: 23039327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
    Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
    Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
    Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
    Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
    Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
    Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
    Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
    Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.